On February 22, 2024, the Food and Drug Administration inspected New Hope Fertility Center located in New York, according to data posted on the FDA’s website.
The FDA’s final report recommended that New Hope Fertility Center address issues related to the management of operations involving human cellular, tissue, and gene therapies. No corrective measures were deemed necessary for blood and blood products.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
